Clinical Trial

Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

Name: Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT — clinical trial record (NCT07319000)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

Low-dose post-transplant cyclophosphamide have demonstrated therapeutic efficacy in allogeneic stem cell transplants which is comparable with the standard dose and also facilitates early hematological recovery.

Trial Details

NCT Number	NCT07319000
Lead Sponsor	Hospital Universitario Dr. Jose E. Gonzalez
Conditions	Graft Versus Host Disease
Enrollment	35 participants
Start Date	2023-01-01
Primary Completion	2023-12-31 (estimated)
Study Completion	2023-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-06